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SYMPOSIUM
TRENDS IN HEALTH CARE DECISIONMAKING
INTRODUCTION
JACK SCHWARTZ*
"Every life is different from any that has gone before it," writes
Dr. Sherwin Nuland in his recent account of the dying process, "and
so is every death. The uniqueness of each of us extends even to the
way we die."1 Can law accommodate itself to that uniqueness? Can
the legal system safeguard the range of individual choices about
dying?
Maryland is a test case of sorts. It has moved from a legal frame-
work that had large gaps and needless restrictions to one that is avow-
edly comprehensive and supportive of individual choice. The
contributors to this Symposium place the Maryland developments in
context, suggest the strengths and potential weaknesses of the new
Maryland law, and give policy-makers elsewhere in the country much
to think about as they consider how their laws ought to be changed to
reflect the changed world at the bed-side.
Certainly, Maryland law before 1988 was wholly inadequate to the
task. In 1988, near the beginning of a long opinion that sought to
clarify the law at the time, the Attorney General of Maryland observed
that decisions about life-sustaining medical treatment were being
* Chief Counsel for Opinions and Advice, Office of the Maryland Attorney General.
BA., University of Maryland Baltimore County, 1972;J.D., Yale University, 1975. The views
expressed in this article are personal and should not be attributed to the Attorney Gen-
eral's Office.
1. SHERWIN B. NULAND, How WE DIE 1 (1994).
1041
MARYLAND LAW REVIEW
made "against a background of legal confusion."2 Attorney General J.
Joseph Curran, Jr. went on to identify the main areas of confusion:
Some believe that the Living Will Law prohibits the withhold-
ing or cessation of artificially administered sustenance under
any circumstances. Others question whether a medical dura-
ble power of attorney is a proper means to state a person's
desire to forgo artificially administered sustenance. On the
question of surrogate decisionmaking, the uncertainty is
even worse.
3
The absence of clear ground rules encouraged the wrong people to
make the decisions-hospital risk managers instead of doctors, doc-
tors instead of patients, judges instead of family members. Those who
decided had insufficient legal guidance when they sought to identify
the proper decisional standards. And uncertainty about who had de-
cisional authority, coupled with health care providers' pervasive ner-
vousness about liability, led to overtreatment.
The 1988 Attorney General's opinion answered a number of
questions by weaving together strands of constitutional and common
law reasoning and statutory construction. The opinion, by validating
the use of the durable power of attorney as an instrument of health
care planning and by strongly affirming the right to refuse artificially
supplied nutrition and hydration, sought to expand the range of indi-
vidual choice beyond the severe limitations of the then-Living Will
Law. Almost everyone found something to disagree with in the opin-
ion; nevertheless, for the most part, health care practitioners and law-
yers accepted the opinion as an acceptable way-station toward
legislation that would codify sound practice.
Nobody, least of all the Attorney General, thought that the opin-
ion was a substitute for legislation. If an opinion of the Attorney Gen-
eral is soundly reasoned, then it makes good predictions about how
the courts would resolve issues under current law. But an opinion
cannot create law. So, for example, the 1988 Attorney General's opin-
ion found only a narrowly circumscribed role for family members in
declining life-sustaining procedures for an incapacitated patient, and
the opinion had to stretch to do that much.4
Of course, the Maryland Court of Appeals can make law if it
wishes to, but only within the confines of the cases that happen to
reach it. In Mack v. Mack,5 the Court described a framework for
2. 73 Op. Att'y Gen. 162, 169 (1988).
3. Id.
4. Id. at 196-201.
5. 329 Md. 188, 618 A.2d 744 (1993).
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health care decisionmaking largely paralleling that foreshadowed in
the 1989'Attorney General's opinion. Keeping to its proper role, how-
ever, the Court in Mack actually determined no more than was neces-
sary to resolve the narrow case before it-that of a patient in a
persistent vegetative state, under guardianship, where close family
members disagreed over whether the patient would want a feeding
tube maintained. Like courts elsewhere in cases of this kind, the
Court of Appeals avoided policy pronouncements that it thought were
best left to the legislature.6
In short, the known inadequacies and the several uncertainties of
Maryland law could only be addressed by comprehensive legislation.
Thus began a several-year process that combined an intensive focus on
the issues and, ultimately, an equally intensive lobbying effort to gain
passage of what became the Health Care Decisions Act of 1993.
The Act is Maryland's new set of ground rules, a thoughtful and
progressive effort to ensure that the right people, applying the right
standards, make health care decisions. The Act has five main goals:
9 To foster patient control over health care choices by
providing flexible tools for advanced planning;
* To keep health care decisionmaking on behalf of in-
capacitated patients in the clinical setting and out of court,
by broadening the power of surrogates, subject to defined
limits and patient-oriented decisional standards;
* To protect incapacitated patients against wrongful de-
cisions to forgo life-sustaining procedures;
* To reaffirm the independence of physicians within a
properly circumscribed sphere of professional expertise;
* To give guidance to judges in deciding the cases
about life-sustaining procedures that inevitably will still come
to court.
Professor SandraJohnson's historical essay7 places in perspective
these developments in Maryland law. The 1988 Attorney General's
opinion and Mack v. Mack were surely part of what Professor Johnson
calls the "principalism" phase in the evolution of bioethics, a phase
dominated by court decisions that sought to identify and apply the
legal principles undergirding individual patient rights. The enact-
ment of the Health Care Decisions Act reflects what Professor John-
son identifies as a new phase in which legislation emerges as a result
6. See David Orentlicher, The Limitations of Legislation, 53 MD. L. REv. 1255, 1257 & n.8
(1994) (citing cases).
7. Sandra H. Johnson, The Changing Nature of the Bioethics Movement, 53 MD. L. REv.
1051 (1994).
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of an increase in public debate, political compromise, and direct
democracy.
8
ProfessorJohnson predicts that the next phase in the evolution of
bioethics will involve the submerging of autonomy-based decisional
principles in favor of the imperatives of "communitarianism" and ra-
tioning. For one who has worked to establish a firm base in Maryland
law for individual choice, however, this transformation of bioethical
thought, if indeed it does occur, will not be a welcome one.
In her richly detailed account of the background to the Health
Care Decisions Act,9 Professor Diane Hoffmann describes the intellec-
tual debate and ultimate political compromise that resulted in the
Act's passage. Her description of the Act's main provisions under-
scores the magnitude of the achievement in attaining enactment of so
comprehensive and advanced a law. And as a principal architect of
both the substance of the Act and the coalition politics that was cru-
cial in securing its passage, Professor Hoffmann has a special entitle-
ment to tell the story.
Yet Professor Hoffmann's main thesis has a certain Manichean
cast to it: that the forces of darkness, promoting their agenda of gov-
ernmental heavy-handedness through the device of legal obscurant-
ism, were put to rout on the fields of Annapolis by the forces of light,
holding aloft the banner of populism and plain English.
From my perspective, this picture is overdrawn; the similarities
between the initially competing bills were far more numerous than
the differences, which indeed narrowed even further as the legislative
session drew closer. The compromise between the bills that allowed
the Act to pass was always within reach. Since it is hard to run double-
blind studies of alternative legislative approaches, no one can say for
sure what would have happened if either the "coalition bill" or the
"committee bill," as Professor Hoffmann dubs them, had been en-
acted intact. I suspect there would have been less actual impact than
Professor Hoffmann's article suggests.
Some of the differences between the two bills reflected honest
disagreement over whether a greater amount of detail in the law
would ultimately promote the values underlying the coalition bill it-
self. What two commentators asked about a law professor's theory (in
a wholly different context) is an apt set of questions about this or any
8. Id. at 1059.
9. Diane E. Hoffmann, The Maryland Health Care Decisions Act: Achieving the Right Bal-
ance?, 53 MD. L. Rrv. 1064 (1994). For another perspective on the evolution of the Health
Care Decisions Act, see John Carroll Byrnes, The Health Care Decisions Act of 1993, 23 U.
BALT. L. REv. (forthcoming Feb. 1995).
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statute: "Is it shadow or substance? Does it clearly separate what's
permitted from what's forbidden? Or does it turn on broad generali-
ties that look fine on the printed page but are too vague for real-life
application?"1"
For example, the coalition bill had no definition at all of the key
term "best interest." Yet private decisionmakers are helped, not hin-
dered, if the law gives them a common understanding of a concept
that all agree is a potential basis for decision. As Dr. Levenson ob-
serves in his piece in this Symposium, "Paradoxically, the [Health Care
Decisions Act's] greater complexity compared to past laws ultimately
facilitates the decisionmaking process and allows greater latitude for
both patients and health care providers. . .. "11
Professor Hoffmann also criticizes the committee bill for its ap-
parent belief "that legislation should be designed for the 'bad actors'
in our society."1" Indeed so; the job of the Legislature, after all, is to
address contingencies: What is the desired outcome if the following
problem comes up? There is no harm in ignoring rarities, but if a
problem occurs frequently or has grave consequences-like some-
one's life at stake-it must be addressed. The trick is to do so, as
Professor Hoffmann rightly argues, without unduly burdening the vast
majority of "good actors." The Health Care Decisions Act, as enacted,
achieves this balance.
Dr. Steven Levenson's analysis of the rights and responsibilities of
health care providers underscores an important point: The Health
Care Decisions Act will fall far short of its promise if health care prov-
iders-especially physicians-are ignorant of it, misunderstand it, or
are indifferent to it. As Dr. Levenson puts it: "Because physicians still
have considerable authority to define reality and to guide treatment
selection, they may help or hinder decisionmaking, depending on
how they assert their rights and fulfill their responsibilities." i"
10. Alex Kozinski & Eugene Volokh, A Penumbra Too Far, 106 HARv. L. REv. 1639, 1644
(1993).
11. Steven A. Levenson, Mayland's 1993 Health Care Decisions Act-Implicationsfor Health
Care Practitioners, 53 MD. L. REv. 1131, 1151 (1994).
12. Hoffmann, supra note 9, at 1102-03.
13. Levenson, supra note 11, at 1133. Awareness of the Act's careful definition of
medically ineffective treatment" is especially important, lest physicians assume broader
decisionmaking authority than the law gives them. Indeed, Dr. Levenson himself provides
an example that goes beyond the definition. Id. at 1145. If a patient will die from a
blocked intestine without surgery, but surgery will remove the blockage and prevent death
from that immediate cause, the surgery is not "medically ineffective," even if surgery is
totally useless in dealing with the condition that caused the blockage in the first place. MD.
CODE ANN., HEALTH-GEN. § 5-601(n) (1994). Perhaps the surgery is not what the patient
would want, given the poor underlying condition, or perhaps surgery would not be in the
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Perhaps the single most important step in implementing the Act
is devising effective strategies for educating physicians about it and
convincing them that paying attention to it will benefit them and their
patients. As Ruth Macklin, a leading bioethicist, recently wrote,
[A]lthough the law can guarantee the moral rights of pa-
tients, physicians by and large are uninformed about legal
details even when legislation or regulation bears directly on
clinical practice. A case in point... is the law in New York
State regarding DNR orders. Despite the fact that the law
has been on the books for several years, many physicians re-
main woefully ignorant about its provisions. 4
Dr. Levenson's article is a good start on the herculean task of educat-
ing physicians about the Health Care Decisions Act.
One of the most significant features of the Health Care Decisions
Act is the role that it assigns to family members and others close to the
patient as "surrogate decisionmakers."15 Professor Jacqueline Glover
examines both the traditional justifications for a family role in medi-
cal decisionmaking and ajustification grounded in the "moral author-
ity of the intimate attachment itself."' 6
Then, more provocatively, Professor Glover suggests that the fam-
ily's own interest, as distinct from that of its patient-member, is enti-
tled to separate weight in the calculus of decisionmaking about the
patient's health care choices: "Patients have obligations ofjustice [to
their families], and families and health care professionals are not enti-
tled to behave as though they do not."' 7 If this means that Grandma
is morally (and legally) justified in filling out an advance directive de-
clining life-sustaining procedures because she wants to preserve her
estate for her grandchildren's college education, few would disagree.
But if it means that a family surrogate, without knowing what
Grandma would want and without regard to Grandma's best interest
understood in terms of Grandma's life, is morally (or legally) justified
patient's best interest, but those are judgments committed to someone other than the
physician.
14. RUTH MACKLIN, ENEMIES OF PATIENTS 235 (1993). One part of Dr. David Oren-
tlicher's contribution to this Symposium is an account of how physicians "generally still
consider it their responsibility to make treatment decisions that they believe are in the
patient's best interest and that patient preferences should be ignored if they are inconsis-
tent with the physician's view of the patient's best interests." Orentlicher, supra note 6, at
1281; see also Hoffmann, supra note 9, at 1092.
15. MD. CODE ANN., HEALTH-GEN. § 5-605 (1994).
16. Jacqueline J. Glover, Should Families Make Health Care Decisions?, 53 MD. L. REV.
1158, 1163 (1994).
17. Id. at 1170.
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in rejecting life-sustaining procedures for her because the family de-
cides that her money would be better spent on the grandchildren's
education, then Professor Glover is describing a decisionmaking re-
gime incompatible with Maryland law, or that of any other state. Of
course, Professor Glover might be writing more as prophet than re-
porter. The law a decade hence may reflect her sense of family pre-
rogatives, but it does not do so today.
Professor Martha Minow's Who's the Patient seeks to place the in-
terests of the family within a process of decisionmaking that continues
to respect patient autonomy as a bedrock consideration. "[D]eparture
from the individual patient," she writes, "cannot be sustained ethically
or conceptually."' 8 As is true of many of the most difficult health care
choices, the purely legal structure for decisionmaking cannot attempt
to resolve the issues that Professor Minow assesses. The law says that a
competent patient has the right to make an informed choice about
health care alternatives; it does not, and should not, interfere with a
broadening of the patient's frame of reference, and that of the pa-
tient's health care providers too, so that the factors influencing the
patient's choice include the impact on those with whom the patient
shares relationships. In fact, the Health Care Decisions Act expressly
recognizes that the patient's solicitude for others is a valid considera-
tion in determining what the patient would want done.19 The patient,
Professor Minow points out, is "someone whose autonomy includes
affirmed membership in families and social groups."20
The Health Care Decisions Act also does something practical that
will greatly benefit families: By expanding the scope of surrogate deci-
sionmaking, most often the Act will keep families from having to en-
dure the emotional and financial burdens of going to court. Judge
John Fader's article 2 1 explains why that is so, why it is a good thing,
and what the decisional standards will be in the cases (mercifully few,
we all hope) that still must come to court.
The philosophical essay by Father Kevin Wildes22 nicely comple-
ments Professor Hoffmann's account of the at-times difficult gestation
of the Health Care Decisions Act, for in Father Wildes's view such
legislative endeavors must be bedeviled by the impossibility of any
18. Martha Minow, Who's the Patient, 53 MD. L. REv. 1173, 1183 (1994).
19. MD. CODE ANN., HEALTH-GEN. § 5-605(c)(2)(vi) (1994); MD. CODE ANN., EST. &
TRUSTS § 13-711(d) (8) (Supp. 1993).
20. Minow, supra note 18, at 1192.
21. John F. Fader II, The Precarious Role of the Courts: Surrogate Health Care Decisionmak-
ing. 53 MD. L. REV. 1193 (1994).
22. Kevin Wn. Wildes, SJ., Particularism in Bioethics: Balancing Secular and Religious Con-
cerns, 53 MD. L. REv. 1220 (1994).
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shared moral underpinning for the legislative policy decisions. 25 Sup-
port for his point about the impossibility of moral consensus in a secu-
lar world may be found in the fact that some of the bitterest
arguments over the Health Care Decisions Act took place over the
wording of the preamble, the uncodified portion of the Act that sets
out lofty principles. Consensus was easier to achieve, as Father Wildes
explains, when the participants in the debate were focussed on spe-
cific procedural points. "People can bring closure to a moral contro-
versy," he writes, "by negotiation and appeal to procedures. . . . If
moral controversies cannot be resolved by a general consensus, par-
ticipants may decide either to abide by some procedure to reach an
answer or to apply external procedures that draw authority from the
permission of those involved." 24 That focus is how the Maryland Gen-
eral Assembly came to closure on the Health Care Decisions Act.
From Father Wildes's view that secular endeavors like state laws
on health care decisionmaking rest on a philosophical foundation of
sand, we move to a world of radical simplicity in the new Uniform
Health-Care Decisions Act, carefully parsed in Charles Sabatino's arti-
cle. 25 The framers of the Uniform Act evidently viewed the world
through a monocular: All is autonomy, spaciously understood to in-
clude even surrogate decisionmaking. 26 In fact, the Uniform Law
Commissioners were so intent on achieving the apotheosis of auton-
omy that they seem blind to threats to true autonomy. For example,
Mr. Sabatino points out that "[e]xecution requirements such as wit-
nessing are absent" from the Uniform Act's provisions on advanced
health-care directives.27 Mr. Sabatino writes that "[p] redictably, some
will criticize the [Uniform] Act for dismissing widely used formalities
such as witnessing protocols and witness restrictions."28 I am happy to
make Mr. Sabatino's prediction come true: An advance directive elic-
ited by coercion or improper influence is hardly a manifestation of
autonomy, and even minimal execution requirements are something
of a safeguard.
23. Father Wildes's philosophical analysis supports this observation of Professor Hoff-
mann: "Unfortunately, in a pluralistic society with few universally agreed-upon moral
precepts, there is no ethical yardstick by which to measure 'rightness' regarding these is-
sues." Hoffmann, supra note 9, at 1129.
24. Wildes, supra note 22, at 1235.
25. Charles P. Sabatino, The New Uniform Health Care Decisions Act: Paving a Health Deci-
sions Superhighway, 53 MD. L. REv. 1238 (1994).
26. Id. at 1250 (stating that the Uniform Act "places substantial faith in the authority of
surrogates as the best way to reinforce patient autonomy").
27. Id. at 1239.
28. Id. at 1241.
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To be sure, there is much in the Uniform Act to be praised: for
example, some useful and clear definitions, properly broad advance
directives, and a workable (though dangerously boundless in scope)
surrogate decisionmaking mechanism to keep cases out of court.
State policy analysts considering a substantial overhaul of a law on
health care decisions will want to look at the Uniform Act as a source
of ideas. However, the Uniform Act's resolute refusal to give any pri-
ority to, or even to pay any attention to, risks to vulnerable patients
will ensure it a much larger place in the footnotes of law reviews than
on the statute books of the states.
Finally, to end the Symposium on a somewhat somber note, Dr.
David Orentlicher29 points to a host of what he views as problems that
are embodied in, or derive from, a statute like the Health Care Deci-
sions Act. For one thing, he writes, patients and health care providers
sometimes erroneously act on an "assumption that certain rights do
not exist without an enabling statute," and that "statutes enunciate the
full extent of a patient's right." 0 So, for example, he points out that
an advance directive law that limits the right to refuse life-sustaining
procedures to a few specified conditions does not give full scope to
the competent patient's constitutional right to refuse treatment no
matter what the patient's condition.
In this regard, Dr. Orentlicher might be underestimating the im-
portance of statutes that make effectuation of the constitutional right
easy. No case holds that a state is constitutionally required to make
procedural formalities minimal or to grant immunity to health care
providers. Without a good statute, there could be even more of a gap
between constitutional theory and bed-side reality than already exists.
That gap, indeed, is the central theme in Dr. Orenflicher's care-
fully documented critical essay, which is as persuasive as it is depress-
ing: that statutes like the Maryland Health Care Decisions Act will fall
far short of their promise so long as "end-of-life decisions, like other
medical decisions, are driven primarily by physician preferences and
values, rather than patient preferences and values.""
Dr. Orentlicher describes a number of factors that produce this
result, including "professional resistance to a loss of authority."32 This
resistance is understandable, for, as Ruth Macklin points out, physi-
cians are besieged, their autonomy "under fire because of the percep-
tion that they have abused the health care system" by costing it too
29. Orentlicher, supra note 6.
30. Id. at 1263.
31. Id. at 1305.
32. Id. at 1294.
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much money, their authority "to recommend what they believe is best
for their individual patients [superseded by] hospital administrators,
risk managers, and bureaucrats at a distance [who] have newfound au-
thority to oversee and constrain physicians' decisions." 31
Dr. Orentlicher presents a number of ameliorative suggestions
for this problem-better education of physicians about bioethical is-
sues, more sensible reimbursement schemes, a strengthening of sanc-
tions against physicians for violations of informed consent, and more
disclosure by physicians of their own values.3 4 Let us hope that these
can be part of the new system of health care that, for better or worse,
is inevitable. For as Dr. Orentlicher concludes pessimistically, "[u] ntil
the dominance of physician values is addressed, no end of life statute
can ensure that patient wishes will be fulfilled."3 5
The French historian Albert Sorel once remarked that "there is
an eternal dispute between those who imagine the world to suit their
policy, and those who correct their policy to suit the world." This
Symposium reflects that dispute, as well it should. Surely it is the role
of critics, especially critics in the academy, to find shortcomings in a
piece of legislation like the Health Care Decisions Act, measured
against a world suited to their policies.
In politics, though, the pure achieve nothing. Flawed as it may
be, the Health Care Decisions Act represents a remarkable transfor-
mation of Maryland policy to suit the complicated world of patients,
families, and doctors. As Dr. Orentlicher in particular suggests, the
Act by itself might not be enough to effect a comprehensive change in
long-held and fiercely defended professional attitudes. Still, it is a
brave effort that will, in many cases, achieve something of profound
importance: It will spare dying patients and their families needless
anguish. Is there any more noble endeavor of the law?
33. MACKLIN, supra note 14, at 244.
34. Orentlicher, supra note 6, at 1302-04.
35. Id. at 1305. One optimistic forecast about changes in the health care system over
the next two decades suggests that patients armed with much more information, thanks to
quantum leaps in technology, will at last be able to dominate the decisionmaking process:
"As the health-care system switches to computers, and information begins to flow freely
among doctors, nurses, drug makers and patients, the health-care market will become
more transparent .... This will encourage more competitive buying not just by insurers
and governments but by patients themselves, making doctors and other health care provid-
ers more accountable than ever before." Alexandra Wyke, The Future of Medicine, THE
ECONOMIST, Mar. 19, 1994, at 16.
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